| # | Drug | Count |
|---|---|---|
| 0 | DEXAMETHASONE | 40 |
| 1 | DEXAMETHASONE 1.5 MG | 40 |
| 2 | LIDOCAINE HYDROCHLORIDE | 34 |
| 3 | FENTANYL | 30 |
| 4 | PROPOFOL | 30 |
| 5 | ROPIVACAINE HYDROCHLORIDE | 27 |
| 6 | ONDANSETRON HYDROCHLORIDE | 25 |
| 7 | SEVOFLURANE | 25 |
| 8 | ONDANSETRON | 22 |
| 9 | LIDOCAINE HYDROCHLORIDE ANHYDROUS | 19 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ROPIVACAINE HYDROCHLORIDE | 27 | 0.0110 |
| 1 | SUCCINYLCHOLINE CHLORIDE | 9 | 0.0040 |
| 2 | SEVOFLURANE | 25 | 0.0030 |
| 3 | KETOROLAC TROMETHAMINE | 15 | 0.0030 |
| 4 | NINTEDANIB ESYLATE | 1 | 0.0029 |
| 5 | BUPIVACAINE HYDROCHLORIDE IN DEXTROSE | 14 | 0.0018 |
| 6 | BUPIVACAINE | 17 | 0.0018 |
| 7 | MEPIVACAINE HYDROCHLORIDE | 2 | 0.0017 |
| 8 | CROTAMITON | 1 | 0.0016 |
| 9 | CILTACABTAGENE AUTOLEUCEL | 8 | 0.0012 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 52 |
| 1 | Amide Local Anesthetic [EPC] | 43 |
| 2 | Opioid Agonist [EPC] | 32 |
| 3 | General Anesthetic [EPC] | 31 |
| 4 | Antiarrhythmic [EPC] | 29 |
| 5 | Serotonin-3 Receptor Antagonist [EPC] | 25 |
| 6 | Platinum-based Drug [EPC] | 22 |
| 7 | Nucleoside Metabolic Inhibitor [EPC] | 20 |
| 8 | Proteasome Inhibitor [EPC] | 15 |
| 9 | Fluoroquinolone Antibacterial [EPC] | 13 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | General Anesthetic [EPC] | 31 | 0.0007 |
| 1 | Amide Local Anesthetic [EPC] | 43 | 0.0005 |
| 2 | Antiarrhythmic [EPC] | 29 | 0.0003 |
| 3 | Antihypoglycemic Agent [EPC] | 1 | 0.0002 |
| 4 | Ester Local Anesthetic [EPC] | 11 | 0.0002 |
| 5 | Recombinant Human Deoxyribonuclease 1 [EPC] | 4 | 0.0002 |
| 6 | Serotonin-3 Receptor Antagonist [EPC] | 25 | 0.0002 |
| 7 | Phosphodiesterase 3 Inhibitor [EPC] | 1 | 0.0002 |
| 8 | Non-Standardized Chemical Allergen [EPC] | 11 | 0.0001 |
| 9 | Tetracycline-class Drug [EPC] | 10 | 0.0001 |